{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:17:23Z","timestamp":1793740643883,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cpcardiol.2026.103328","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:06:07Z","timestamp":1772899567000},"page":"103328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac rehabilitation in overweight and obese patients: Challenges, strategies, and the role of emerging anti-obesity therapies"],"prefix":"10.1016","volume":"51","author":[{"given":"Mariarosaria","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Roberto","family":"Modestino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alsergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Galzerano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Saldamarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bossone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103328_bib0001","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ehjqcco\/qcac014","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021: executive summary","volume":"8","author":"Timmis","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103328_bib0003","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103328_bib0004","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1253\/circj.CJ-23-0820","article-title":"Impact of long-term exercise-based cardiac rehabilitation in patients with chronic heart failure- A systematic review and meta-analysis","volume":"88","author":"Yamamoto","year":"2024","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012264","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"2016","author":"Anderson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2021.11.001","article-title":"Impact of cardiorespiratory fitness on outcomes in cardiac rehabilitation","volume":"70","author":"Tutor","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0007","series-title":"The National Audit of Cardiac Rehabilitation: Quality and Outcomes Report 2018","author":"Doherty","year":"2018"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejim.2021.04.028","article-title":"Physical activity in management of persons with obesity","volume":"93","author":"Oppert","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0009","article-title":"Barriers and facilitators to weight-loss in patients with overweight\/obesity and cardiac disease: a realist qualitative synthesis","volume":"19","author":"Bates","year":"2024","journal-title":"Int J Qual Stud Health N Hav Well-being"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/2277-9175.96077","article-title":"The effect of the cardiac rehabilitation program on obese and non-obese females with coronary heart disease","volume":"1","author":"Ghashghaei","year":"2012","journal-title":"Adv Biomed Res"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103328_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9149(97)89239-9","article-title":"Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients","volume":"79","author":"Lavie","year":"1997","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103328_bib0012","article-title":"Health-related quality of life and cardiac rehabilitation: does body mass index matter?","volume":"52","author":"den Uijl","year":"2020","journal-title":"J Rehabil Med"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103328_bib0013","article-title":"Differential effects of cardiac rehabilitation in Obese and Non-Obese population","volume":"13","author":"Atti","year":"2021","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103328_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102995","article-title":"Obesity treatment: weight loss versus increasing fitness and physical activity for reducing health risks","volume":"24","author":"Gaesser","year":"2021","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103328_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3810\/psm.2011.05.1898","article-title":"Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals","volume":"39","author":"Gaesser","year":"2011","journal-title":"Phys Sportsmed"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103328_bib0016","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","article-title":"The relationship between obesity and mortality in patients with heart failure","volume":"38","author":"Horwich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","article-title":"Updates on obesity and the obesity paradox in cardiovascular diseases","volume":"78","author":"Tutor","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0018","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCULATIONAHA.106.679779","article-title":"Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"116","author":"Kenchaiah","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103328_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.5535\/arm.2016.40.5.924","article-title":"Comparison of the effects of cardiac rehabilitation between obese and non-obese patients after acute myocardial infarction","volume":"40","author":"Lim","year":"2016","journal-title":"Ann Rehabil Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103328_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mayocp.2012.11.020","article-title":"Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure","volume":"88","author":"Lavie","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103328_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4065\/mcp.2009.0562","article-title":"Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years","volume":"85","author":"McAuley","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/HCR.0000000000000026","article-title":"Impact of an outpatient cardiac rehabilitation program on clinical and analytical variables in cardiovascular disease","volume":"34","author":"Roca-Rodr\u00edguez","year":"2014","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"19\u201320","key":"10.1016\/j.cpcardiol.2026.103328_bib0023","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/jocn.12233","article-title":"Factors that influence obesity, functional capacity, anxiety and depression outcomes following a phase III cardiac rehabilitation programme","volume":"22","author":"McKee","year":"2013","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjcard.2022.05.016","article-title":"Weight loss and its predictors during participation in cardiac rehabilitation","volume":"178","author":"Hushcha","year":"2022","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103328_bib0025","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/oby.21160","article-title":"Weight loss outcomes in patients with pain","volume":"23","author":"Masheb","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40608-016-0098-0","article-title":"Predictors of early attrition and successful weight loss in patients attending an obesity management program","volume":"3","author":"Jiandani","year":"2016","journal-title":"BMC Obes"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc12-0733","article-title":"Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP)","volume":"36","author":"Delahanty","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-11-1","article-title":"Changes in self-reported and parent-reported health-related quality of life in overweight children and adolescents participating in an outpatient training: findings from a 12-month follow-up study","volume":"11","author":"Finne","year":"2013","journal-title":"Health N Hav Qual Life Outcomes"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0029","article-title":"Factors predictive of drop-out and weight loss success in weight management of obese patients","volume":"28","author":"Had\u017eiabdi\u0107","year":"2015","journal-title":"J Hum Nutr Diet"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1159\/000345951","article-title":"Clinical correlates of weight loss and attrition during a 10-week dietary intervention study: results from the NUGENOB project","volume":"5","author":"Handjieva-Darlenska","year":"2012","journal-title":"Obes Facts"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0031","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2021.04.063","article-title":"Obese patients' characteristics and weight loss outcomes in cardiac rehabilitation: an observational study of registry data","volume":"337","author":"Wilkinson","year":"2021","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103328_bib0032","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzad055","article-title":"Effects of a dedicated cardiac rehabilitation program for patients with obesity on body weight, physical activity, sedentary behavior, and physical fitness: the OPTICARE XL randomized controlled trial","volume":"103","author":"den Uijl","year":"2023","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103328_bib0033","first-page":"55","article-title":"Comparing the effects of a cardiac rehabilitation program on functional capacity of obese and non-obese women with coronary artery disease","volume":"8","author":"Sadeghi","year":"2012","journal-title":"ARYA Atheroscler"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0034","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1378\/chest.109.1.52","article-title":"Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease","volume":"109","author":"Lavie","year":"1996","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103328_bib0035","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/oby.2012.119","article-title":"Obesity negatively impacts aerobic capacity improvements both acutely and 1-year following cardiac rehabilitation","volume":"20","author":"Martin","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103328_bib0036","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.hipert.2023.05.007","article-title":"Effects of cardiac rehabilitation on obese hypertensive patients: a controlled trial","volume":"40","author":"Baykal Sahin","year":"2023","journal-title":"Hipertens Riesgo Vasc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103328_bib0037","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1559-4572.2008.00002.x","article-title":"Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients","volume":"3","author":"Lavie","year":"2008","journal-title":"J Cardiometab Syndr"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103328_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113883","article-title":"Effectiveness of intensive cardiac rehabilitation in high-risk patients with cardiovascular disease in real-world practice","volume":"13","author":"\u015awi\u0105tkiewicz","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103328_bib0039","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1467-789X.2009.00703.x","article-title":"Obesity and mobility disability in the older adult","volume":"11","author":"Vincent","year":"2010","journal-title":"Obes Rev"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103328_bib0040","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","article-title":"Sleep apnea: types, mechanisms, and clinical cardiovascular consequences","volume":"69","author":"Javaheri","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103328_bib0041","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13679-015-0153-z","article-title":"Health consequences of weight stigma: implications for obesity prevention and treatment","volume":"4","author":"Puhl","year":"2015","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0042","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rehab.2016.09.002","article-title":"Stress, anxiety and depression in heart disease patients: a major challenge for cardiac rehabilitation","volume":"60","author":"Chauvet-Gelinier","year":"2017","journal-title":"Ann Phys Rehabil Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103328_bib0043","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/obr.12266","article-title":"Impact of weight bias and stigma on quality of care and outcomes for patients with obesity","volume":"16","author":"Phelan","year":"2015","journal-title":"Obes Rev"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103328_bib0044","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s40279-018-0930-4","article-title":"Exercise prescription in patients with different combinations of cardiovascular disease risk factors: a consensus statement from the EXPERT working group","volume":"48","author":"Hansen","year":"2018","journal-title":"Sports Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103328_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. a position paper from the secondary prevention and rehabilitation section of the European association of preventive cardiology","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0046","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.apmr.2023.02.005","article-title":"Cost-effectiveness of a cardiac rehabilitation program specifically designed for patients with obesity within the OPTICARE XL randomized controlled trial","volume":"104","author":"Visser","year":"2023","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0047","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/09638288.2022.2050428","article-title":"Cardiac rehabilitation designed for patients with obesity: OPTICARE XL RCT results on health-related quality of life and psychosocial well-being","volume":"45","author":"den Uijl","year":"2023","journal-title":"Disabil Rehabil"},{"issue":"Suppl 1","key":"10.1016\/j.cpcardiol.2026.103328_bib0048","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11606-017-3987-0","article-title":"Behavioral treatment for veterans with obesity: 24-month weight outcomes from the ASPIRE-VA small changes randomized trial","volume":"32","author":"Lutes","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/HCR.0000000000000021","article-title":"Daily steps threshold to improve cardiovascular disease risk factors during the year after an acute coronary syndrome","volume":"33","author":"Houle","year":"2013","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103328_bib0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-023-02805-1","article-title":"Echocardiographic follow-up after cardiac rehabilitation designed for patients with obesity","volume":"39","author":"Snelder","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0051","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2024.04.041","article-title":"Long-term efficacy and safety of once-weekly semaglutide for weight loss in patients without diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"222","author":"Moiz","year":"2024","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.cpcardiol.2026.103328_bib0052","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103328_bib0053","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","volume":"13","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103328_bib0054","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.cpcardiol.2026.103328_bib0055","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103328_bib0056","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.cpcardiol.2026.103328_bib0057","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1056\/NEJMoa2505928","article-title":"Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes","volume":"393","author":"Nicholls","year":"2025","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.cpcardiol.2026.103328_bib0058","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103328_bib0059","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103328_bib0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide-semaglutide in adults with overweight or obesity and type 2 diabetes","volume":"393","author":"Davies","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0061","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - A phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103328_bib0062","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S2213-8587(23)00356-X","article-title":"Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial","volume":"12","author":"le Roux","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103328_bib0063","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-monthly Maridebart cafraglutide for the treatment of obesity - a phase 2 trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103328_bib0064","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-8587(25)00216-5","article-title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Knop","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2026.103328_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103328_bib0066","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgs.16372","article-title":"Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium","volume":"68","author":"Bhasin","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103328_bib0067","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-8587(25)00027-0","article-title":"Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:47:05Z","timestamp":1779511625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0146280626000708"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103328","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac rehabilitation in overweight and obese patients: Challenges, strategies, and the role of emerging anti-obesity therapies","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103328"}}